Abbott Laboratories 2012 Annual Report Download - page 65

Download and view the complete annual report

Please find page 65 of the 2012 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

63
Abbott 2012 Annual Report
Year Ended December 31 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Summary of Operations:
Net Sales $39,873.9 38,851.3 35,166.7 30,764.7 29,527.6 25,914.2 22,476.3 22,337.8 19,680.0 17,280.3 15,279.5
Cost of products sold $15,119.7 15,540.6 14,665.2 13,209.3 12,612.0 11,422.0 9,815.1 10,641.1 8,884.2 7,774.2 6,820.5
Research and development (a) $ 4,322.2 4,129.4 3,724.4 2,743.7 2,688.1 2,505.6 2,255.3 1,821.2 1,696.8 1,623.8 1,474.5
Selling, general
and administrative $12,059.5 12,756.8 10,376.3 8,405.9 8,435.6 7,408.0 6,349.7 5,496.1 4,921.8 4,808.1 3,724.9
Operating earnings $ 8,084.5 5,751.9 6,087.6 6,235.7 5,693.8 4,578.5 2,042.2 4,362.3 3,898.3 2,974.0 3,151.9
Interest expense $ 592.4 530.1 553.1 519.7 528.5 593.1 416.2 241.4 200.2 188.3 238.9
Interest income $ 79.2 (85.2) (105.5) (137.8) (201.2) (136.8) (123.8) (87.7) (51.1) (41.9) (33.5)
Other (income), net (b) $ 1,316.8 158.6 (62.0) (1,375.5) (489.7) (347.5) (526.5) (411.3) (376.4) (559.5) (374.4)
Earnings from continuing
operations before taxes $ 6,262.6 5,198.6 5,712.8 7,193.8 5,856.3 4,469.6 2,276.4 4,619.9 4,125.6 3,387.2 3,321.0
Taxes on earnings from
continuing operations $ 299.7 470.2 1,086.7 1,447.9 1,122.1 863.3 559.6 1,247.9 949.8 882.4 774.0
Earnings from
continuing operations $ 5,962.9 4,728.4 4,626.2 5,745.8 4,734.2 3,606.3 1,716.8 3,372.1 3,175.8 2,504.7 2,547.0
Basic earnings per share
from continuing operations $ 3.76 3.03 2.98 3.71 3.06 2.34 1.12 2.17 2.03 1.60 1.63
Diluted earnings per share
from continuing operations $ 3.72 3.01 2.96 3.69 3.03 2.31 1.12 2.16 2.02 1.59 1.62
Financial Position:
Working capital $18,042.4 8,288.5 5,055.1 10,264.4 5,106.8 4,939.5 (669.3) 3,970.5 3,908.8 2,650.9 2,119.6
Long-term investments $ 273.6 378.2 302.0 1,132.9 1,073.7 1,125.3 1,229.9 134.0 145.8 406.4 250.8
Net property and equipment $ 8,063.0 7,874.0 7,971.0 7,619.5 7,219.2 7,518.1 6,946.4 6,003.1 6,007.9 6,281.8 5,828.1
Total assets $67,234.9 60,276.9 60,573.9 52,581.6 42,419.2 39,713.9 36,178.2 29,141.2 28,767.5 26,039.3 23,592.7
Long-term debt $18,085.3 12,039.8 12,523.5 11,266.3 8,713.3 9,487.8 7,009.7 4,571.5 4,787.9 3,452.3 4,274.0
Shareholders’ investment $26,813.2 24,526.1 22,765.1 23,187.4 17,518.7 17,823.9 14,054.2 14,415.3 14,325.8 13,072.3 10,664.6
Return on shareholders’
investment from
continuing operations % 23.2 20.0 20.4 28.4 26.9 22.7 12.1 23.5 23.8 22.6 28.0
Book value per share $ 17.01 15.62 14.53 14.76 11.26 11.47 9.14 9.37 9.18 8.36 6.82
Other Statistics:
Gross profit margin % 62.1 60.0 58.3 57.1 57.3 55.9 56.3 52.4 54.9 55.0 55.4
Research and development
to net sales % 10.8 10.6 10.6 8.9 9.1 9.7 10.0 8.2 8.6 9.4 9.7
Net cash from
operating activities
of continuing operations $ 9,314.4 8,970.1 8,736.0 7,275.2 6,994.6 5,183.8 5,262.1 5,047.4 4,306.0 3,385.2 3,653.5
Capital expenditures $ 1,795.3 1,491.5 1,015.1 1,089.0 1,287.7 1,656.2 1,337.8 1,207.5 1,291.6 1,050.1 1,105.4
Cash dividends declared
per common share $ 1.67 1.92 1.76 1.60 1.44 1.30 1.18 1.10 1.04 0.98 0.94
Common shares
outstanding (in thousands) 1,576,667 1,570,379 1,546,984 1,551,168 1,552,433 1,549,910 1,537,243 1,539,235 1,560,024 1,564,518 1,563,068
Number of
common shareholders 60,476 62,939 64,413 67,461 69,733 73,176 77,727 82,237 88,582 91,212 94,687
Number of employees 92,939 91,922 91,440 72,868 68,838 68,697 66,663 59,735 60,617 58,181 57,819
Sales per employee (in dollars) $ 429,033 422,655 384,588 422,198 428,943 377,225 337,163 373,948 324,662 297,010 264,265
Market price per share – high $ 72.47 56.44 56.79 57.39 61.09 59.50 49.87 50.00 47.63 47.15 58.00
Market price per share – low $ 53.96 45.07 44.59 41.27 45.75 48.75 39.18 37.50 38.26 33.75 29.80
Market price per share – close $ 65.50 56.23 47.91 53.99 53.37 56.15 48.71 39.43 46.65 46.60 40.00
(a) In 2012, 2011, 2010, 2009, 2006, 2005, 2004, 2003, 2002 and 2001 Abbott also recorded pretax charges of $288, $673, $313, $170, $2,014, $17, $279, $100, $108 and $1,330,
respectively, for acquired in-process research and development.
(b) 2012 includes $1,350 for the net loss on extinguishment of debt.
Summary of Selected Financial Data
(dollars in millions, except per share data)